Gi Dynamics (GID) Short Interest
Gi Dynamics (ASX:GID) had 0.00% of shares reported as short positions as of 4 Dec 2017, representing 21,970 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Gi Dynamics
Gi Dynamics, Inc focuses on the development and commercialization of innovative medical devices for the treatment of metabolic diseases. The company is known for its EndoBarrier product, a non-surgical therapy for type 2 diabetes and obesity. Gi Dynamics aims to address the growing global epidemic of these conditions with its unique endoscopic approach.
Short position
Gi Dynamics (ASX:GID) has 0.00% of its shares on issue reported as short positions as of 4 Dec 2017, or about 21,970 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.46% in September 2014. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4GID intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Gi Dynamics, Inc Cdi Us Prohibited
Be the first to discuss GID
Start a research thread or post the first pulse update